US20100066544A1 - Health Monitoring Apparatus and Methods - Google Patents

Abstract

A measurement module for glucose testing includes a glucose testing measurement module housing, a test strip receptacle formed in the housing, and a connector portion formed in the housing and shaped to permit mechanical removable attachment of the housing to a hand-held computer. Electronics determine the amount of glucose present in a sample of body fluid, when the test strip is positioned in the receptacle and the body fluid is placed on a test strip, and communicate the glucose amount to the hand-held computer via the connector portion.

Description

• This application is a continuation patent application of U.S. patent application Ser. No. 10/112,671, filed Mar. 29, 2002, which claims the benefit of priority to U.S. provisional patent applications No. 60/300,011, filed Jun. 20, 2001, and 60/280,905, filed Apr. 2, 2001, which are assigned to the same assignee as the present application and are hereby incorporated by reference.
BACKGROUND OF THE INVENTION
• 1. Field of the Invention
• The invention relates to blood glucose monitoring, and particularly to a blood glucose monitor and data management and display device integrated as a synchronous, handheld unit, as an effective and efficient diabetes management tool.
• 2. Discussion of the Related Art
• Blood glucose self-measurements have been conventionally taken by diabetics. The diabetic uses a blood glucose measuring tool. The diabetic typically pricks his or her finger using a lancet. A droplet of exposed blood is applied to a sensor strip which is placed in the glucose measuring tool. A reading appears on a display of the measuring tool indicating the blood glucose level of the diabetic.
• Diabetics sometimes use a computer having some form of software that permits the user to track the glucose measurements they have taken. The glucose measurements are typically loaded into the computer manually by the diabetic. Other transfer methods are possible that require steps by the diabetic in order that the information gets entered into the computer, e.g., transferring glucose readings that have been retained in memory of the measuring tool via a cable to the computer. The data may be sent to a health care professional who may also be keeping an eye on the diabetic's status. It is an object of this invention to provide a more efficient and reliable process of taking the measurement, determining the glucose level, entering the glucose level data into a diabetes management program, and managing the diabetes condition using diabetes management software.
• In the past, the glucose measurement tool could be carried by the patient for use almost anywhere. However, access to data entry and management using the computer and software have been relegated to a PC setup at a fixed location such as the patient's home, and so these steps had to wait until the diabetic arrived back at his or her home. In the present invention, it is recognized that the development of hand-held devices such as PDAs and mobile phones and PDA/mobile phone combined units could permit diabetics to enter data and use the data management software away from their PCs. It is therefore an object of this invention to provide a system that permits data entry and management by the diabetic away from the diabetic's PC. In addition, it is desired to have a device that permits this mobile data entry and management, and yet permits the user to take off-finger measurements, or using so-called alternate site testing.
• Conventional methods have utilized two very separate instruments, the glucose measurement tool and the PC. It is an object of this invention to provide a synchronous tool that performs the conventional functions of both the glucose measurement tool and PC, and perhaps additional features and advantages. It is a further object to synergistically provide this tool, such as by using a same power source and/or a same display for both purposes, i.e., glucose measurement and data management and/or analysis.
SUMMARY OF THE INVENTION
• In view of the above, and in particular accordance with the above objects, a measurement module for glucose testing is provided including a glucose testing measurement module housing, a test strip receptacle formed in the housing, and a connector portion formed in the housing and shaped to permit mechanical, removable attachment of the housing to a hand-held processing device, hand-held computer, PDA, mobile phone or wireless processing device. Electronics are provided either in the measurement module or in the hand-held processing device for determining the amount of glucose present in a sample of body fluid, when a test strip is positioned in the receptacle and the fluid is placed on the test strip, and for communicating the glucose amount to the processing device via the connector portion.
• The test strip is typically inserted into the test strip receptacle so that the system may calibrate in preparation for application of the body fluid to the strip. Insertion of the strip may further initiate an activation of electrical components that participate in the testing of a body fluid sample. When the system is ready after connecting the measurement module with the hand-held processing device, and after insertion of the strip into the receptacle in the measurement module, and after any calibration or component activation, then the system display preferably indicates that the body fluid is to be now applied to the strip for testing. An alternative system may be or may become available to those skilled in the art wherein the body fluid is applied to the strip, and/or calibration/component activation occur, before strip insertion, and if such system would otherwise include one or more features of preferred embodiments herein, then such systems may also be within the scope of a preferred embodiment.
• The housing of the glucose testing measurement module is configured so that a sample of body fluid may be easily applied to the strip when the module is connected to the hand-held processing device and the strip is inserted into the receptacle in the measurement module. The end of the housing from which the strip protrudes is substantially narrowed compared with the end that connects with the hand-held processing device. This narrowed end is preferably a tapered trapezoidal profile, is preferably rounded in two or three directions, protrudes from the connector end defining a shoulder or inset particularly for matching an alternate site body contour and is preferably made of low durometer material, so that the module can rest comfortably and securely on a body location near the test site for easy and precise application of the body fluid to the strip. This configuration of the housing is particularly advantageous when off-finger or alternate site testing is desired such as at an arm or a leg site.
• The test strip may be side-filled and may also be tip-filled. Use of a side-filled strip is particularly advantageous for alternate site testing. For example, the module may be rested near the alternate test site (for example a forearm) with a user contacting a rounded shoulder of the housing on the user's skin. The device is then rocked comfortably into a test strip side-fill contact position with the body fluid, due to the ergonometric and/or arthopometric design of the module. For this purpose the module preferably has no square or sharp edges exposed when fitted with the handheld processing device. Even when using a tip-filled strip, exposed edges of the module are preferably rounded for rocking the strip into tip-filled contact with the body fluid, even though the depth of the module is small compared with its width particularly at the wider connection end, and contact with the user may be established perhaps only at a single point on the narrowed end when the body fluid in applied to the strip. The test strip advantageously uses only a relatively small amount of body fluid sample for performing reliable tests, such as less than 1 microliter. Measurements are conducted preferably using a coulometric technique, and alternatively an amperometric, reflectrometic or other technique understood by those skilled in the art, which is significant for alternate site testing wherein typically a lower volume of sample is made available by a same lancing operation at an alternate site than when testing is performed on the finger.
• The removable connectability of the measurement module with the hand-held processing device is greatly facilitated by electronics that integrate the two components of this integrated system. An isolation barrier is provided for safe glucose monitoring and/or analysis, even though power is preferably supplied to the module from the hand-held processing device, while also data is transferred between the measurement module and hand-held processing device. The power is preferably transformer-coupled, or alternatively capacitatively-coupled, between the isolated and non-isolated sides of the barrier. Analog front-end signal acquisition circuitry of the measurement module allows signals including data indicative of a blood glucose level or other test of the body fluid to be acquired by the measurement module. Opto-isolators preferably isolate data I/O circuitry and provide a data signal transport route across the barrier to the hand-held processing device so that the data can be analyzed there and/or easily uploaded to a PC by HotSync. By “HotSync”, what is meant is any method of synchronizing data in the handheld with data in a PC, such as by cable, cradle, infrared or radio link. By “analyze”, it is meant that the hand-held processing device can do more than merely display a glucose measurement value. For example, charts, plots and graphs of compiled glucose data can be generated and additional factors such as diet, exercise, insulin regimen, etc., may be used to process and/or display various information relating to a diabetic condition or regimen. Serial to parallel conversion circuitry permits parallel access to a data/address bus of the hand-held processing device to the data transported across the barrier.
• In a particular embodiment, a measurement module for glucose testing is further provided including a test strip receptacle in a glucose measurement module, a connector portion formed in the module shaped to permit connection of the module to a hand-held computer by inserting the connector portion of the glucose measurement module into a receptacle defined within the hand-held computer, and electronics for determining the amount of glucose present in a sample of body fluid, when the fluid is placed on a test strip and the test strip is positioned in the receptacle, and for communicating the glucose amount to the hand-held computer via the connector portion.
• A glucose monitoring apparatus is further provided including a measurement module configured to couple with a test sensor and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is coupled with the measurement module and body fluid is applied to the test sensor.
• A further glucose monitoring apparatus is provided including a measurement module configured to couple with a test sensor and a hand-held processing device electrically and mechanically coupled with and separable from the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is coupled with the measurement module and body fluid is applied to the test sensor.
• A glucose monitoring apparatus is also provided including a measurement module configured to couple with a test sensor and a hand-held processing device configured to receive data transmission from the measurement module. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement after the test sensor is coupled with the measurement module and body fluid is applied to the test sensor. The monitoring apparatus includes a single display at the processing device.
• A glucose monitoring apparatus is further provided including a measurement module not having a display for displaying results of glucose measurements, the module being configured to couple with a test sensor, and a hand-held processing device configured to receive data transmission from the measurement module. The measurement module and the processing device form a synchronous unit for performing and analyzing a glucose measurement after the test sensor is coupled with the measurement module and body fluid is applied to the test sensor. The processing device includes a display for displaying the results of said glucose measurements.
• A glucose monitoring apparatus is further provided including a measurement module configured to couple with a test sensor and a hand-held processing device configured to receive a data transmission from the measurement module. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement. The processing device is configured for automatically receiving the data transmission after the test sensor is coupled with the measurement module and body fluid is applied to the test sensor.
• A method of performing a glucose measurement using a measurement module and a hand-held processing device is provided including coupling the processing device electrically and mechanically with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after a test sensor is inserted into the measurement module, coupling the test sensor with the measurement module, applying body fluid to the test sensor and reading a glucose level from a display on the integrated hand-held unit.
• A method of performing a glucose measurement using a measurement module and a hand-held processing device is also provided including coupling the processing device with the measurement module to receive a data transmission from the measurement module such that the measurement module and the processing device form a synchronous unit including a single display on the processing device for performing and analyzing a glucose measurement after a test sensor is inserted into the measurement module, coupling the test sensor with the measurement module, applying body fluid to the test sensor and reading a body fluid glucose level from the display on the processing device.
• A method of performing a glucose measurement using a measurement module and a hand-held processing device, is further provided including inserting the measurement module into a receptacle defined within the processing device for the processing device to receive a data transmission from the measurement module, such that the measurement module and the processing device form an integrated, hand-held unit for performing and analyzing a glucose measurement after a test sensor is inserted into the measurement module, coupling the test sensor with the measurement module, applying body fluid to the test sensor and reading a glucose level from a display on the processing device.
• The invention further includes a method of performing a glucose measurement using a measurement module and a hand-held processing device including coupling the processing device with the measurement module to automatically receive a data transmission from the measurement module after a test sensor is inserted into the measurement module, such that the measurement module and the processing device form a synchronous unit for performing and analyzing a glucose measurement, coupling the test sensor with the measurement module, applying body fluid to the test sensor and reading a glucose level from a display.
• A glucose monitoring apparatus is further provided including a measurement module configured to couple with a test sensor, and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The measurement module is further geometrically configured to enable off-finger or alternate site application of blood to the test strip.
• A glucose monitoring apparatus is also provided including a measurement module configured to couple with a test sensor, and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The measurement module is rounded in three dimensions for providing smooth off-finger or alternate site points of contact with the skin of a person being tested.
• A glucose monitoring apparatus is further provided including a measurement module configured to couple with a test sensor, and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The measurement module is rounded in at least two dimensions for providing smooth off-finger or alternate site points of contact with the skin of a person being tested.
• A glucose monitoring apparatus is also provided including a measurement module configured to couple with a test sensor, and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The measurement module includes a telescoping trapezoidal profile for permitting placement of a test strip inserted within the module at an off-finger or alternate site location of a person being tested.
• A glucose monitoring apparatus is also provided including a measurement module configured to couple with a test sensor, and a hand-held processing device electrically and mechanically coupled with the measurement module to form an integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The measurement module includes an encapsulation port for the test sensor and a PC board including an opto-isolation component. The measurement module extends less than two inches in length and less than one half inch in thickness beyond dimensions of the wireless processing device.
• A software program for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test sensor and a hand-held processing device is further provided. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The processing device is configured to HotSync with a PC. The software program includes instructions for a processor to perform the steps of creating a replica database on the PC of the glucose data stored in a device database on the processing device, and synchronizing the glucose data to a PC database program. The synchronizing step includes reading the glucose data stored in the device database on the processing device, matching the data to corresponding data in the replica database, format converting the data and writing the data to the replica database.
• A software program for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test strip and a hand-held processing device is also provided. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement after the test strip is inserted and body fluid is applied to the test strip. The processing device is configured to HotSync with a PC. The software program includes instructions for a processor to perform the steps of measuring glucose data from the test strip having body fluid applied thereto, automatically downloading the glucose data from the measurement module to the processing device, and downloading the glucose data to a personal computer.
• A method for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test sensor and a hand-held processing device. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The processing device is configured to HotSync with a PC. The method includes creating a replica database on the PC of the glucose data stored in a device database on the processing device, and synchronizing the glucose data to a PC database program. The synchronizing step includes reading the glucose data stored in the device database on the processing device, matching the data to corresponding data in the replica database, format converting the data, and writing the data to the replica database.
• A method for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test strip and a hand-held processing device is also provided. The measurement module and processing device form a detachably integrated, hand-held unit for performing and analyzing a glucose measurement after the test strip is inserted and body fluid is applied to the test strip. The processing device configured to HotSync with a PC. The method includes measuring glucose data from the test strip having body fluid applied thereto, automatically downloading the glucose data from the measurement module to the processing device after measuring said glucose data, and downloading the glucose data to a personal computer.
• A software program for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test sensor and a hand-held processing device is further provided. The measurement module and processing device form a synchronous unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The software program includes instructions for a processor to perform the steps of measuring glucose data, providing a sensory output of a glucose level corresponding to the data, and automatically entering the data into a database accessible by a diabetes management software program.
• A method for analyzing glucose data measured with a glucose monitoring apparatus which includes a measurement module configured to couple with a test sensor and a hand-held processing device. The measurement module and processing device form a detachably integrated, hand-held unit for performing and analyzing a glucose measurement after the test sensor is inserted and body fluid is applied to the test sensor. The method includes measuring glucose data, providing a sensory output of a glucose level corresponding to the data, and automatically entering the data into a database accessible by a diabetes management software program.
BRIEF DESCRIPTION OF THE DRAWINGS
• FIG. 1 schematically shows a plan view of an integrated glucose measurement module and hand-held processing device, such as a personal digital assistant or PDA, or mobile phone, integrated phone and PDA, or other wireless device, according to a preferred embodiment.
• FIG. 2 shows a block diagram of electrical modules of the integrated glucose measurement module and PDA ofFIG. 1.
• FIGS. 3aand3bschematically illustrate an advantageous electrical isolation barrier feature of an integrated module and PDA according to a preferred embodiment.
• FIG. 4 shows an electrical circuitry schematic of a glucose measurement module for integrating with a PDA according to a preferred embodiment.
• FIG. 5 shows an electrical circuitry schematic of a PDA for integrating with a glucose measurement module according to a preferred embodiment.
• FIG. 6aschematically shows a bottom plan view of a glucose measurement module for integrating with a PDA according to a preferred embodiment.
• FIG. 6bschematically shows a rear view of the glucose module ofFIG. 6a.
• FIG. 6cschematically shows a bottom perspective view of the glucose module ofFIG. 6a.
• FIG. 6dschematically shows a top perspective view of the glucose module ofFIG. 6a.
• FIG. 6eschematically shows a side view of the glucose module ofFIG. 6a.
• FIG. 6fschematically shows a front view of the glucose module ofFIG. 6a.
• FIG. 6gschematically shows another side view of the preferred glucose module with preferred dimensions shown in millimeters.
• FIG. 6hschematically shows a top view of the preferred glucose module with preferred dimensions shown in millimeters.
• FIG. 6ischematically shows another rear view of the preferred glucose module with preferred dimensions shown in millimeters.
• FIG. 7aschematically shows a side view of the measurement module ofFIG. 6aintegrated with a PDA according to a preferred embodiment.
• FIG. 7bschematically shows a plan view of the integrated measurement module and PDA ofFIG. 7a.
• FIG. 8 illustrates a glucose data handling system software according to a preferred embodiment in block diagram form.
• FIG. 9 illustrates a hardware/software block diagram of an integrated glucose measurement module and PDA according to a preferred embodiment.
• FIG. 10 shows a data flow diagram of an integrated glucose measurement module and PDA according to a preferred embodiment.
• FIG. 11 shows a software data flow diagram of an integrated glucose measurement module and PDA according to a preferred embodiment.
• FIG. 12 illustrates a line graph of blood glucose data generated by an integrated measurement module and PDA according to a preferred embodiment.
• FIG. 13 illustrates pie charts of blood glucose data generated by an integrated measurement module and PDA according to a preferred embodiment.
INCORPORATION BY REFERENCE
• What follows is a cite list of references each of which is, in addition to the background, the invention summary, the abstract and the claims, hereby incorporated by reference into the detailed description of the preferred embodiments below, as disclosing alternative embodiments of elements or features of the preferred embodiments not otherwise set forth in detail below. A single one or a combination of two or more of these references may be consulted to obtain a variation of the preferred embodiments described in the detailed description below. Further patent, patent application and non-patent references are cited in the written description and are also incorporated by reference into the preferred embodiment with the same effect as just described with respect to the following references:
• U.S. patent application Ser. No. 09/413,565, 60/300,011 and 60/280,905, which are assigned to the same assignee as the present application;
• Published U.S. application Ser. Nos. 2002029058, 2002025469, 2002008038, 2001054319, and 2001017269, which are also assigned to the same assignee as the present application;
• U.S. Pat. Nos. 5,307,263, 5,601,435, 5,899,855, 5,974,124, 6,153,062, 6,330,426, 6,334,778, D427,312, D439,242, D426,638, D424,696 U.S. Pat. Nos. 6,338,790, 6,329,161, D450,854, U.S. Pat. Nos. 6,299,757, 6,294,281, 6,281,006, 6,251,260, 6,175,752, 6,120,676, 6,103,033; and GB 1579690, GB 2225637, GB 2194892, GB 2073891, GB 2154003, and GB 2204408; and
• EP 0504835, EP 0799896, EP 0800082, EP 0880936, EP 0048090, EP 0078636, EP 0096288, EP 0125139, EP 0136362, EP 0170375, EP 0080304, EP 0184909, EP 0206218, EP 0230472, EP 0241309, EP 0245073, EP 0278647, EP 0286084, EP 0359831, EP 0368209, EP 0390390, EP 0400918, EP 0453283, EP 0470290, EP 0255291, EP 0127958, EP 0781406 and EP 1147739 A2; and
• PCT applications No. WO 86/00513, WO 89/02246, WO 90/00367, WO 95/06240, WO 96/07907, WO 96/07908, WO 96/07893, WO 97/20207, WO 97/41421, WO 97/46868, WO 98/09167, WO 98/24366, WO 98/52045, WO 99/05966, WO 99/32883, WO 99/467582, WO 00/13580, WO 00/20626, WO 00/33065, WO 00/78210, WO 01/24038, WO 01/52727, WO 01/33216, WO 01/57238, WO 01/57239, WO 01/67009, WO 85/05119, WO 89/08713, WO 90/05300, WO 91/04704, WO 92/13271, WO 94/20602, WO 94/27140, WO 95/02817, WO 97/00441, WO 97/18464, WO 97/19344, WO 97/42882, WO 97/42883, WO 97/42886, WO 97/42888, WO 97/43962, WO 99/08106, WO 01/88524, WO 01/36430, WO 01/36660, WO 00/78992 and WO 99/30152; and
• Schrezenmeir, et al., Computer Assisted Insulin Dosage Adjustment-Perspectives for Diabetes Control, Hormone and metabolic Research, Supplement Series Vol. No. 24, pp. 116-123 Theme Medical Publishers (1990);
• A. Michael Albisser, Intelligent Instrumentation in Diabetic Management, Vol. 17,Issue 1, pp. 1-24 (1989);
• J. Stuart Soeldner, Treatment of Diabetes Millitus by Devices, the American Journal of Medicine, Vol. 70, 183-194 (January 1981);
• New Computer Uses Can Improve Diabetics' Lot, The American Journal of Pharmacy, Vol. 70, pp. 144, 146 (February 1989);
• Hiroyuki Norio, Clinical Telecommunication Network System for Home Monitoring, Med. & Biol. Eng. & Comput., 32, 227-230 (March 1994);
• A. S. Douglas et al., Hand-Held Glucose Monitor and Recorder, Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, New Orleans, 747-748 (Nov. 4-7, 1988);
• User's Guide, Accu-Chek Compass Diabetes Care Software, Roche Diagnostics, pp. 1-93 (2000);
• Laughton E. Miles, A Portable Microcomputer for Long-Term Physiological Monitoring in the Home and Work Environment, pp. 47-57, Raven Press, eds. Laughton E. Miles and Roger). Broughton (1990);
• P. G. Fabietti et al., Wearable System for Acquisition, Processing and Storage of the Signal from Amperometric Glucose Sensors, International Journal of Artificial Organs, Vol. 14, No. 3, pp. 175-178 (1991);
• Heller, A., “Amperometric biosensors based on three-dimensional hydrogel-forming epoxy networks,” Sensors and Actuators B, 13-14:180-183 (1993);
• Heller, A., “Electrical Connection of Enzyme Redox Centers to Electrodes,” J. Phys. Chem, 96(9):3579-3587 (1992); and
• Heller, A., “Electrical Wiring of Redox Enzymes,” Acc. Chem. Res., 23(5):129-134 (1990).
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
• FIG. 1 schematically shows a perspective view of an integratedglucose measurement module2 and a hand-heldprocessing device4, such as preferably a personal digital assistant (PDA)4 or a mobile phone or combined PDA/phone or other wireless device with a processor as may be understood by those skilled in the art. Hereinafter when the term PDA is used it is meant to refer to any of these or other hand-held processing devices, any of which may also be operated using hands-free accessories and/or equipment. The glucose measurement module2 (hereinafter “module2”) is shown inFIG. 1 mechanically attached to thePDA4. Themodule2 is in this way physically mounted to and integrated with thePDA4. Themodule2 is also electrically connected to thePDA4 when mounted into thePDA4. In addition, themodule2 is software interfaced with thePDA4 when mounted into thePDA4. Themodule2 shown inFIG. 1 preferably does not have a display, since the display of thePDA4 may be used for displaying information. ThePDA4 may be replaced by another processing device having a display such as a mobile phone having a connector for attaching themodule2.
• The module is shown having aslot6 for insertion of an invitro test strip8. Some details may be found at U.S. patent application Ser. No. 09/413,565, which is assigned to the same assignee as the present application and is hereby incorporated by reference. When thetest strip8 is inserted into theslot6, preferably blood such as whole blood, plasma and/or serum, and alternatively another body fluid such as interstitial fluid, sweat, urine, tears, saliva, dermal fluid, spinal fluid, etc., is applied to thestrip8 and themodule2 measures the glucose level of the body fluid applied to thestrip8. Hereinafter, whenever blood or body fluid is referred to for being applied to thestrip8, it is meant to include whatever body and/or biological fluid that may be applied tostrip8 for testing. The glucose level data automatically transfers to the PDA4 (the data transfer mechanism is described in more detail below with reference toFIGS. 2-5), and the glucose level in the blood tested is displayed on thedisplay10 of thePDA4, or transmitted through a speaker or otherwise to a user of the device shown inFIG. 1.
• ThePDA4 is configured to HotSync with a PC for transmitting data to a PC. ThePDA4 may also transmit data by wireless RF and/or IR connection to a remote or host client or server computer. ThePDA4 also preferably has internet connectability or is otherwise configured for logging into a network for transmitting and receiving data from the network.
• FIG. 2 shows a block diagram of electrical modules of the integratedglucose measurement module2 andPDA4 ofFIG. 1. At the point of the in vitrotest strip slot6 at the top ofFIG. 2 is astrip interface12 including circuitry for connecting to an in vitro test strip for passing a current through blood applied to the strip.Glucose measurement circuitry14 is shown connected to thestrip interface12 for measuring one or more parameters indicative of a blood glucose level of the blood applied to the strip. Anisolated power module15 provides power to theglucose measurement circuitry14 andstrip interface12 and ultimately to the test strip.
• Anisolation barrier16 is shown for isolating the power at the module from the power at thePDA4. Theisolation barrier16 is provided to protect the user from having a high current pass through his or her body when thePDA4 is in aHotSync cradle18 and thus is connected to AC power. Since an electrically conductive part of the integratedmeasurement module2/PDA4 system (i.e., a strip) contacts the patient, the system may be considered to have a “patient applied part” and would be bound to comply with applicable standards (AAMI ES1, IEC60601-1-2, etc) for isolated patient connections. These standards contain requirements for a maximum amount of current that can flow in either direction between the patient and an AC power line or ground with either themodule2 or the patient in contact with 110% of line voltage.
• When theglucose measurement module2 is inserted into thePDA4 and thePDA4 is connected to it'sHotSync cradle18 as shown inFIG. 2, AC ground is connected to themodule2. This connection is made because the ground connection of theHotSync cradle18 to thePDA4 is connected to ground at the computer to which the HotSync cradle is connected, which is in turn connected to earth ground at the AC outlet. If AC voltage is applied to thestrip connector12, a large amount of current would flow to AC ground through themodule2,PDA4,HotSync18, and/or computer circuitry.
• Referring toFIG. 3a, amodule20 connected toPDA circuitry22 and not having theelectrical isolation barrier16 ofFIG. 2 is illustrated. Apatient28 is shown contacting atest strip30, e.g., for applying blood to the strip or for inserting the strip into themodule20. Thepatient28 is also contactingAC power26 which also powers acomputer24. Thecomputer24 is shown communicating with thePDA22 through theHotSync cradle18. AC ground is shown connected to thecomputer24, theHotsync cradle18, thePDA circuitry22, and themodule20. If theuser28 became in contact with thetest strip30 and inadvertently came in contact with any earth referenced potential, large currents would flow through theuser28, and back to earth ground via this path. Conversely, if themodule20 ortest strip30 were to be inadvertently raised to a high potential reference to earth ground, again large currents would flow through theuser28. The risk in each case is electrocution of theuser28 and the standards consider having theuser28 in contact with significant potentials a viable scenario. Should even very small currents flow across the heart, e.g., there is significant risk of causing fibrillation.
• In order to prevent this potentially dangerous situation, electrical connections which come into contact with theuser28 at thestrip connector30 are advantageously isolated from earth ground or AC in accord with a preferred embodiment.FIG. 3billustrates the scenario described above with respect toFIG. 3aexcept that themodule2 includes theisolation barrier16 referred to above with reference toFIG. 2. Theuser28 who is shown inFIG. 3bin contact withAC power26 to thecomputer24 is also contacting thestrip30 which is connected to themodule2. In contrast with the scenario illustrated byFIG. 3a, thestrip30 is not connected to AC ground, and thus no currents pass through theuser28.
• Thisisolation barrier16 is preferably created via a physical or otherwise insulating gap in the circuitry on the PC board or themodule20. A preferred dimension of this gap is around 4 mm and is generally dictated by electrical safety standards.
• Referring back now toFIG. 2, theglucose measurement circuitry14 andstrip interface12 are shown on the isolated side of thebarrier16. Power for this isolated circuitry is created bypower transfer circuitry32, which is a transformer coupled, switching power supply according to a preferred embodiment. Thetransformer32 bridges theisolation barrier16 and transfers isolatedpower15 to the isolated side of thebarrier16 from the PDA-to-module interface connector34. For sufficiently low power consumption requirements, a capacitively-coupled supply would be a viable alternativepower transfer circuitry15.Switching control circuitry36 is on the PDA (ground referenced) side of theisolation barrier16.
• A glucose value is calculated bycircuitry14 on the isolated side of thebarrier16. The glucose value, status, and errors are communicated across theisolation barrier16 preferably via a bidirectionalserial interface38. Control commands may be preferably received from thePDA4 via thissame interface38. Serial communication lines of theserial interface38 bridge theisolation barrier16 preferably via optoisolators (not shown, but seeFIG. 5 and discussion below). Serial information is converted to parallel by serial toparallel conversion circuitry40 within themodule2 on the PDA side of thebarrier16, so that themodule2 can communicate with thePDA4. ThePDA interface42 at themodule connector34 is parallel access directly to a PDA data/address bus ofPDA circuitry44. Thisinterface42 includes control lines as well as power connections.
• As an alternative to providing an electrical isolation barrier betweenmodule2 andPDA4, features can be incorporated intomodule2 that prevent it from being used at the same time thatPDA4 is connected to a HotSync cradle or cable, thereby eliminating the risk of passing high levels of electric current through the cradle or cable to or from the patient. This can be accomplished by providing an extended portion of the housing ofmodule2 that extends down alongPDA4 to interfere with the attachment of a cradle and/or cable toPDA4 whenmodule2 is first attached thereto, or prevent the attachment ofmodule2 when a cradle or cable is already attached toPDA4.
• FIG. 4 shows an electrical circuitry schematic of a glucose measurement module for integrating with a PDA according to a preferred embodiment. The electrical schematic shown inFIG. 4 shows astrip connector52 for making electrical connection to astrip8 inserted into theslot6 of themodule2 ofFIG. 1. Analog front endsignal acquisition circuitry54 is shown for acquiring signals indicative of a blood glucose level in blood applied to the strip8 (FIG. 1). Amicroprocessor56 is shown for controlling themodule4. Themicroprocessor56 receives isolated power (seeelement15 ofFIG. 2) as isolated voltage IVcc from an unregulated voltage atpoint58 of the schematic ofFIG. 4 appearing on the isolated side of the barrier (which is thebarrier16 ofFIG. 2), and regulated throughregulator60.
• FIG. 5 shows an electrical circuitry schematic of a PDA for integrating with a glucose measurement module according to a preferred embodiment. Aconnector62 for mounting themodule2 with thePDA4 as shown inFIG. 1 is shown next to amemory64 for storing digital data. At the right inFIG. 5 is a universal asynchronous receiver/transmitter orUART66. The UART is on the non-isolated side of thebarrier16 ofFIG. 2. The UARTs perform the serial to parallel conversion ofelement40 ofFIG. 2.
• Data is transmitted serially from theglucose module2 to the UART66 (orconverter40 of themodule2 ofFIG. 2) throughoptoisolator68. Data is transmitted serially from theUART66 to the isolated side of thebarrier16 ofFIG. 2 through theoptoisolator70. Data may alternatively be transferred across thebarrier16 in parallel. Additional optoisolator components would be used for parallel data transfer compared with serial transfer. Serial transfer is preferred and allows themodule2 to be smaller, more economical to manufacture and more power efficient than if parallel transfer and additional optoisolators are used.
• Power is transferred from thePDA4 through the transformer (corresponding to thepower transfer circuitry32 ofFIG. 2). The transformer is preferably a 1:1 transformer, and may be a step-down or step-up transformer of a desired ratio. Through the transformer, power as voltage Vcc is transferred from the non-isolated side of thebarrier16 to the isolated side asisolated power76. The power may be around 3.3 Volts according to a preferred embodiment.
• FIG. 6aschematically shows a plan view of aglucose measurement module78 for integrating with a PDA (not shown, but seeFIGS. 7a-7b) according to a preferred embodiment. Themodule78 includes a mountingportion80 and a specially shapedextension portion82. When themodule78 is inserted into a PDA and is mechanically and electrically attached to the PDA and configured to transfer data to/from the PDA, the mountingportion80 is within the PDA and theextension portion82 protrudes outside of the PDA.
• The module78 (corresponding to themodule2 ofFIG. 2) is about 54 mm wide at the mountingportion80 which plugs into thePDA4 and scales down to around 23 mm at theend86 of theextension portion82 where thestrip8 ofFIG. 1 is inserted. Theextension portion82 itself measures about 54 mm in width at the other end where the mountingportion80 begins and theextension portion82 is preferably about 28 mm long from the mountingportion80 to thestrip insertion end86. The shoulder from which theextension portion82 narrows most drastically in about 8.5 mm in extent o the approximately 28 mm extent of theextension portion82. The curvature from the shoulder is about 0.5 rho, which changes direction at a curvature of about 0.5 rho and which changes direction again at a curvature of about 0.6 rho to thestrip insertion end86. As the shoulder flattens out, it makes an angle of about 100° with the elongated direction of themodule78 from thestrip end86, or 80° looking at it from the direction of the mountingportion80, which angle can be varied somewhat while maintaining the shoulder and also the smoothness of the rounding of theextension portion82. Theextension portion82 is shown symmetric, but may have an arbitrary curvature on one side themodule78 will be used by resting the extension portion on only the side with rounded features as just described, i.e., it is preferred there are no sharp corners on at least one side of theextension portion82, and it is more particularly preferred that no sharp corners exist anywhere on theextension portion82, nor even on the mountingportion80.
• The mountingportion80 connects electrically and for data transfer to the PDA by preferably a68 pinelectrical connector84 as shown inFIG. 6bfor connecting to a complementary68 pin male connector of the PDA, wherein the male and female configuration may be reversed or mixed. The thickness of themodule78 is indicated as preferably around 19 mm.FIG. 6bschematically shows a rear view of the glucose module ofFIG. 6a. Although not shown, themodule78 attaches mechanically in place in the PDA receptacle by a pair of mechanical latches preferably on opposing sides, e.g., the left and right side inFIG. 6a, of the PDA receptacle.
• Theextension portion82 is particularly ergonometrically and/or arthopometrically configured so that a patient may insert a strip into a strip insertion slot (corresponding to slot6 ofFIG. 1) at theend86 of theextension portion82, and so that the patient can contact the strip with a drop of blood on the skin of the patient's body. The device is configured so that the patient may choose to use his or her arm, leg or any convenient anatomic location including the finger. This is advantageous because conventional systems often require application of blood to the strip at the finger.
• A feature of the shape of theextension portion82 is its protruding and/or telescoping trapezoidal profile. A utility design is provided at theextension portion82 of themodule78 that promotes easy and efficient manipulation of the glucose strip on the blood drop whether if be on or off-finger or at an alternate site. The PDA module design incorporates a telescoping trapezoidal profile that allows ease of placement and inhibits the PDA body from encroaching or otherwise interfering with the placement, e.g., at a patient's arm. At the same time, the design is unobtrusive, streamlined and safe.
• The telescopic and/or protruding trapezoidal profile of the module includes generous radii on each of the compound edges shown inFIG. 6a. The design allows easy and effective collection of a blood sample from any approved site on the body. The design allows for ease of positioning the module in the proximity of the blood drop and when actually placing the glucose strip on the blood drop. The preferred radii of curvature of each of the three bends on each side of theslot86 of theextension portion82 ofFIG. 6aare drawn to scale. The curvatures are selected such that the PDA does not interfere with the blood application to the strip, e.g., from a patient's arm, leg or other approved off-finger location, and such that the shoulders of theextension portion82 of themodule78 may rest gently on the patient's arm while the blood is applied, if the patient chooses, e.g., for support and/or stability. In addition, the design allows for a discreet and unobtrusive profile extending from the PDA. The design is compact and portable and preferably does not include cumbersome and potentially hazardous cables and extra attachments.
• Theextension82 is preferably rounded in three dimensions or at least two dimensions, e.g., as illustrated by the various views of the preferred embodiment shown inFIGS. 6c-6f, and as mentioned, preferably has no sharp corners on at least one side which may be rested upon an arm or leg near an alternate site testing location, and for displaying information while testing on each arm for different tests such as on different days, theextension82 is preferably rounded on both side and is particularly preferably symmetric as shown.FIG. 6cschematically shows a bottom perspective view of theglucose module78 ofFIG. 6awithextension portion82, mountingportion80 andpin connector84.FIG. 6dschematically shows a top perspective view of theglucose module78 ofFIG. 6awith mountingportion80,extension portion82 andstrip insertion end86.FIG. 6eschematically shows a side view of theglucose module78 ofFIG. 6a, indicating a total length of about 85 mm, a thickness of about 14 mm at theextension portion82 and a thickness of about 0.9 mm at the mountingportion80, wherein theextension portion82 and mountingportion80 couple in a staggered fashion with eachportion80 and82 having an edge which looks out somewhat over the other.FIG. 6fschematically shows a front view of the glucose module ofFIG. 6awith thestrip insertion portion86 showing at the end of theextension portion82. The corners are rounded with radius of curvature about 2.6 mm in the middle of the curve.
• FIGS. 6g,6hand6ischematically show another side view, a top view and another rear view of the preferred glucose module with preferred dimensions shown in millimeters. Referring toFIG. 6g, the mountingportion80 of themodule78 has a thickness of around 14.3 mm, which differs from the 0.9 mm thickness shown atFIG. 6e. The thickness, as well as the width and/or length, of the mountingportion82 is preferably set to adapt to the dimensions of the receptacle of the hand-held processing device (e.g., PDA, mobile phone, combined PDA/phone, etc.) that themodule78 is to be connected, and these dimensions will vary depending on the device, and so no fixed numeric dimensions are necessarily universally preferred. The rounding of thestrip insertion end86 of theextension portion82 is shown as having minimum radii of curvature of 9 mm on the bottom side and 2.5 mm on the top side. Referring toFIG. 6h, the rounding from the shoulder of the extension portion has a minimum radius of curvature around 12 mm, while the rounding which is opposite in direction as the rounding from the shoulder has a curvature radius of about 33 mm and that final rounding near thestrip insertion end86 is about 22 mm at minimum. Referring toFIG. 6i, a thickness of around 19.5 mm is shown for the rear view, which shows thepin connector84, including the thickness of the mountingportion80 added with the staggered overlooking portion of theextension portion82, as briefly described above, i.e., so that the staggered overlook portion of theextension portion82 is about 5 mm.
• As shown inFIGS. 6a-6i, theextension portion82 is rounded away from each side of theslot86 in two orthogonal directions, and rounds from theslot86 toward the mountingportion80, corresponding to a third direction in which theextension portion82 of themodule78 is rounded. This advantageous design prevents potential hazards such as pinching, lacerations, cuts or skin abrasions, during normal use and handling.
• Themodule78 serves as a housing for the strip connector, PC board and the opto-isolation components, while not appearing bulky or obtrusive. As mentioned above, themodule78 does not include a display such as a LCD screen because the PDA display may be used as an advantageous PDA accessory for displaying blood glucose levels without delay due to the integrated design of themodule78 with the PDA (seeFIG. 1). This contributes to the compactness feature of the design, enabling themodule78 to entend less than two inches beyond the end of the PDA, and as shown inFIG. 6a, less than 1.5 inches and even below 1.2 inches. Themodule78 at theextension portion82 is around or less than 0.25 inches thicker than the PDA. Themodule78 weighs less than two ounces and the preferred embodiment shown is around 1.1 ounces, while the design may be configured at less than one ounce. In contrast, if a display such as an LCD were included in themodule78, themodule78 would likely be 50-60% longer, 0.25 inches thicker and be at least two ounces. Thepreferred module78 thus does not have a display, and is thus smaller and lighter than if it did have a display, while the integrated module-PDA system has full display capability. Obtaining power to runmodule78 from the PDA rather than from an internal power source also contributes to the light, compact arrangement shown.
• Themodule78 shown and described with respect toFIGS. 6aand6bincluding the telescoped, trapezoidal-shaped design has fully-radiused shoulders in an advantageous profile. Some preferred radii and compound angle values are shown inFIG. 6a. From theslot86, the design rounds toward the PDA at a preferred radius of curvature of 0.6 rho, then rounds in the opposite direction away from theslot86 at a preferred 0.5 rho and then reverses its curvature again toward the PDA at a preferred 0.5 rho.
• Themodule78 advantageously mates with a PDA device and forms a single, hand-held unit for glucose measuring and data management. The mechanical design shown inFIGS. 6a-6fallows measurements to be taken that suppress problems that might otherwise present themselves such as interference by the bulky PDA in the blood application process, improper strip placement and positioning, potential for injury, and obtrusiveness. The glucose monitoring strip may be positioned to apply the blood drop, while being attached to themodule78 which is itself mounted into the PDA. The sheer size of the PDA in relation to themodule78 does not inhibit the application process due to the design of theextension portion82 such that the PDA body does not interfere with or become a hindrance to placement. The shape the profile of the module actually conforms to the shape of a body part such as an arm to which it rested, without presenting itself with an “arm-sliding” problem, as the user positions themodule78 in close proximity to the blood drop. The rounded shape, generous radii and material selection reduce potential hazards to the user, in terms of cuts, lacerations or skin abrasions.
• Alternative designs would provide for a more pointed profile to themodule78 to presumably provide easier access to the glucose strip or themodule78 may be alternatively connected through a strip connector and a flexible cable to allow flexibility of placement, independent of the PDA body. These alternative designs are not preferred, however, as the size of the pointed profile may be limited by the size of the strip connector and would likely not allow the user to effectively position the strip due to a lack of plastic real estate. Additionally, a flexible cable, although affording flexibility of placement, would be cumbersome and visibly obtrusive. The preferred design thus has the slightly wider tip such as shown inFIG. 6aand no cumbersome cable is used in the preferred embodiment which includes themodule78 directly mechanically coupled with the PDA.
• Themodule78 and particularly theextension portion82 are made of a low durometer material or thermoplastic elastomer facepad detail on both sides of the enclosure, to act as a gripping surface for module insertion and extraction, as well as afford the module a measure of shock absorption. The material may preferably be a PC-ABS alloy or other non-filled plastic resin.
• FIG. 7aschematically shows a side view of themeasurement module78 ofFIG. 6aintegrated with aPDA4 according to a preferred embodiment. An indication of an staggered overlook portion of theextension portion82 being 6.25 mm as opposed to the 5 mm shown about, again indicates that the dimensions of themodule78 can be varied to meet the specifications of the particular hand-helddevice4 being used. The mountingportion80 is shown inserted into thePDA4 while theextension portion82 is shown protruding from thePDA4.FIG. 7bschematically shows a plan view of the integratedmeasurement module78, with mountingportion80 andextension portion82, andPDA4 ofFIG. 7a. As shown, theextension portion82, with length of about 28 mm, protrudes from thePDA4 while the mountingportion80 of theglucose measurement module78, with overall length of about 73 mm, is inserted within the receptacle of the PDA4 (or other hand-held processing device, see above).
• FIG. 8 illustrates generally a glucose data handling system software according to a preferred embodiment in block diagram form.FIG. 8 shows ameasurement module90 which receives aglucose strip92 for measuring a glucose level of blood applied to thestrip92. Themeasurement module90 communicates with the PDA which may be running a Palm operating system or other PDA operating system software. Themeasurement module90 is preferably configured to turn off nonessential electronics when no measurement is being made. The measurement module preferably includes a microprocessor that controls internal timing, algorithms, result calculation and fault determination, among other responsibilities. Themodule90 includes circuitry to connect the serial output of its internal microprocessor to PDA electronics including a mechanism for program initiation and data transfer. Themodule90 also preferably provides electronic ESD protection on analog strip connector lines and flash memory for storage of meter firmware and associated user preferences. Themodule90 is preferably powered by the PDA, but could alternatively include its own power source, such as button or AAA-size batteries. Themodule90 includes electrical isolation between the strip connector and the HotSync port.
• The PDA communicates with a PC when the PDA is preferably HotSynced to the PC. The PDA includes RAM as a temporary database for diabetes management application data and/or programs and non-volatile memory for permanent data and/or program storage. The measurement of the glucose level may however be advantageously performed when the PDA is not HotSynced to the PC, and the PDA includes many data processing features itself for managing data without support from the PC. For example, charts and/or graphs may be generated on the PDA display. The PC system includes standard peripheral devices such as amonitor98,keyboard100, CD-rom102 and aprinter104.
• FIG. 9 illustrates a hardware/software block diagram of an integratedglucose measurement module2 andPDA4 according to a preferred embodiment. Themeasurement module2 shown includes astrip connector52 and analogfront end electronics54, such as those shown inFIG. 4. Themeasurement module2 also shows aprocessor running firmware110, wherein the processor may be as theprocessor56 shown inFIG. 4. The processor is shown having access tonon-volatile data storage112. Theisolation barrier16 is shown wherein the above-mentioned components of themeasurement module2, i.e., thestrip connector52, analogfront end electronics54, processor andfirmware110 andnon-volatile data storage112, are on the isolated side of thebarrier116. PDA meter user interface firmware114 permits themodule2 to communicate with thePDA4. A serial to parallel interface, such as that shown inFIG. 2, is also shown inFIG. 9 for converting the serial data transmitted across thebarrier16 usingoptoisolators68,70 such as thos described above with respect toFIG. 5. Aninterface116 is shown between themodule2 andPDA4.
• ThePDA4 is shown having a PDA RAM and non-volatile storage118, aPDA processor120, a PDA display andtouchscreen122 and a PDAserial interface124. The PDA is configured to HotSync to aPC system96, such as that described above with respect toFIG. 8, including amonitor98,keyboard100, CD-rom102 andprinter104. The PC system shown inFIG. 9 also includes ahard drive126, aCPU128 and a serial I/O130 which alternatively may be USB.
• The data may be entered on thePDA4. This data may be HotSynced to thePC96. The data may also be entered on thePC96 and reverse HotSynced to thePDA4. In the former case, e.g., thePC96 would have an application stored in its memory for accepting this data. This PC application would display and print logbook data in various formats. The PC application would also export data to various data processing applications. The application may use a Microsoft Access Database or MDB format, while the data on the PDA may be stored using the Palm PDB format.
• The user is preferably able to reverse HotSync data from the PC in order to restore the data to the state it was when it was last HotSynced. The user might want to do this in the event the database on the PDA becomes corrupted. The PC application and database may store a complete history of data that was entered on the PDA. The PDA user may choose to archive some of the PDA data on the PC.
• A conduit program may be used. The program may perform the following steps: (1) create a replica of the data stored on the PDA, on the PC; and (2) synchronize data from the PDA to the database on the PC. The two steps may be performed in two separate conduit programs. Synchronizing the data may include reading data from a PDB file and writing it to the PC database. Microsoft Visual Studio may be used for opening, reading and writing data in the PC database. The data may be read from the PDA, matched to data on the PC, format converted, and written to the PC database. Similarly, data entered or modified on the PC may be matched to data on the PDA. The data on the PDA may be updated to reflect the changes made on the PC.
• To match data from the PDA to the PC, unique ID numbers may be used in records on the two systems. These ID numbers may be created on the PDA as logbook records or on the PC as logbook entries there. The uniqueness of the ID numbers may be achieved by pre/post fixing the ID with an origin code identifying PC or PDA, or alternatively perhaps a GUID.
• To read data from a PDA file and write it to the PC database, it is recognized herein that data in the PC database may be organized into tables, which may be organized into records, which may be broken down into predefined fields. Similarly, at some level data will be organized into records with a consistent field structure on the PDA.
• The conduit program reads the data from the PDA file(s) and writes it out to PC tables. The conduit program also reads data from the PC tables and writes them out to PDA file(s). Various types of data conversion may be used. For example, data residing in fields in the PDA file may be converted from the format it exists in the PDA file to a format compatible with the PC and vice-versa. The logical structure of the records in the two systems may be different. Tables may be created (either in code or in an external file such as a database) which define the mapping of data in fields of one system to data in fields in the other. Data may be stored in temporary table(s) that may later be synchronized with main table(s) that contain a complete logbook history, or the conduit program may write to these tables directly.
• FIG. 10 shows a data flow diagram of an integratedglucose measurement module2 andPDA4 according to a preferred embodiment. Current is flowed to astrip8 from themeasurement module2 which, as mentioned, is powered by thePDA4 as shown and described with respect toFIG. 5. Themeasurement module2 includes asetup component132, which themodule2 communicates to thePDA4, and a user preferences, calibration code andglucose log component134.Component134 serves to convert an electrical reading, such as the current that passes through the blood on thestrip8, to a glucose level, saves a glucose log, saves user preferences, and provides status and error data to thePDA4. Error data may include glucose errors and charge errors. ThePDA4 is also configured to send user preferences and a calibration code to themeasurement module2 for use or storage by thecomponent134.
• ThePDA4 also receives firmware revision data, measurement state data and temperature data from themeasurement module2. The measurement state and temperature are preferably displayed on adisplay10 of thePDA4 or otherwise provided to a patient by sensory output such as audio or vibration output. Thedisplay10 is preferably also configured to function with touchscreen software andelectronics135. ThePDA4 includes a timer andpower module136, information about which is also displayed. Data regarding the current time is also sent to themodule2 from the timer andpower module136 of thePDA4.
• The PDA advantageously also includes anevent database138 and auser preferences database140. Theevent database138 generally includes information relevant to diabetes management, such as glucose readings. Fields of an event may include time, data, event type. The glucose and error data are stored to theevent database138 after thePDA4 receives the data from themodule2. The event database includes a logbook which collects glucose, insulin, carbohydrate and exercise data and time. The data in theevent database138 may be graphed in many ways according to helpful default or pre-programmed graphs or according to filtering and preferences inputs from a user. Some exemplary graphs that may be generated on thePDA display10 from the event database and software loaded on the PDA without the PDA being HotSynced or otherwise connected to a PC or other processing device. In addition, the data including glucose data is automatically sent to thePDA4 from themodule2 to be stored in theevent database138 where the data can be used to generate graphs that help a user such as a diabetes patient to track glucose and other information. The data measured by themodule2 does not need to be manually entered by the user into a computer before the data can be processed into graphs and the like, or so that the PDA's own software can process or analyze the data to provide useful data analysis to the patient regarding the glucose and other information relating to the condition of the patient. Software on the PDA also preferably includes insulin and carbohydrate tools, and software for communicating with a PC. Theuser preferences database140 may store user input such as units of measure, date and time format, an audible or otherwise sensory alert level, the language to be used and other user preferences.
• ThePC96 such as that schematically shown atFIGS. 8 and 9 may have additional features. For example, the PC may be configured for viewing and printing the logbook stored on thePDA4 and transferred to thePDA4. The PC may be configured to take glucose values and put them into a data management database of its own that may have the same or different capabilities as the event database loaded on thePDA4. The PC would be helpful for backing-up data and for downloading applications programs to the PDA and also for communicating with other computers over one or more networks. Additional data processing features of the system of the preferred embodiment herein are set forth below with reference toFIG. 11.
• FIG. 11 shows a software data flow diagram of an integratedglucose measurement module2 andPDA4 according to a preferred embodiment.FIG. 11 shows how four software applications according to a preferred embodiment interact and illustrate functions of these applications and databases that the applications are programmed to utilize. The applications include ameter application150, alogbook application152, adiabetes management application154 and adata management application156. Each of these applications preferably runs on the PDA which has been described above (e.g., seeFIG. 10). These applications may also each run on a PC to which the PDA is configured to communicate. The applications may be downloaded to the PDA or another device from the PC or a server or other digital data storage device such as a CD-rom or magnetic disk.
• FIG. 11 also shows alogbook database158 and a carbohydrate (“carbo”)database160. Thedatabases158 and160 are generally electronic stored records. These may be separate databases or parts of a same database. The logbook and carbo databases may be part of theevent database138 mentioned above with reference toFIG. 10. Thelogbook database158 is preferably utilized by each of theapplications150,152,154 and156 mentioned above and shown inFIG. 11, and includes automatic and manual glucose entries, insulin, exercise, meal and other data, and applies user preference filters. Thecarbo database160 is preferably utilized by thediabetes management application154, and includes default carbohydrate data and user entered data. Diabetes management generally refers to activities performed by an individual with diabetes to organize and optimize aspects of life with diabetes such as medication, diet, and exercise that are involved in treating and managing the diabetic condition. The diabetes management application facilitates these activities for the diabetic. The data management application generally provide graphic representations and/or text summaries of data relevant to diabetes management.
• Thelogbook database158 preferably includes time and date tagged events which are automatically or manually stored such as glucose measurements, manually entered glucose readings, exercise records, insulin injection records, meal time records, state of health records, note records, and medication among others. The user may input entries to thelogbook database158, e.g., that are derived from other glucose meters. Manually entered glucose readings may be flagged as user input rather than meter input. The user may enter other items such as insulin amount, type, and time period, meal times and carbohydrate values, exercise time, type, and degree of exertion (e.g., high, medium, low), state of health, comments and medications. These items may be available to the user from a predefined drop down list that can be edited and added to, or can be manually entered. Data associated with a past event may be entered or modified in thedatabase158 by the user. Events may be tagged with time periods.
• Each application150-156 is configured to process user inputs including glucose measurements. For example, the meter application is configured to process calibration code input, glucose readings and button presses. The glucose readings are advantageously automatically stored in thelogbook database158 on the PDA according to the programming of themeter application150. Thelogbook application152 is configured to process stored log data and manual entries, and to store and retrieve the log stored log data and manual entries into and from thelogbook database158, respectively. Thediabetes management application154 is configured to process a daily regimen and events such as exercise, meals, insulin dosages and times, etc. and to store and retrieve the daily regimen and events into and from thelogbook database158, respectively. Thediabetes management application154 is also configured to store and retrieve carbo data and manual carbo entries into and from thecarbo database160, respectively. Thedata management application156 is configured to process structured data with user filters applied, and to store and retrieve automatic and manual entry information into and from the logbook database, respectively.
• Thedata management application156 may be configured to allow the user to view data summaries in graphical and text formats. The user may be able to select the length of time to be viewed. The user may also be able to set a default length of time to be viewed from within user preferences. The user may be able to view a complete data set or filter the screen display to show only a selected time period to view. The user may be able to select the event type to be displayed, more than one event type may be selected to be displayed simultaneously. Glucose summary statistics may be displayed by a selected date range and time period. Both selected date range and time period may appear on the display. The summary statistics may include the number of measurements, the highest measurement, the lowest measurement, the average measurement, the standard deviation of the measurements, the percentage of measurements within the target range, the percentage of measurements above the target range, the percentage of measurements below the target range, and insulin and carbohydrate statistics summary. Graphical summaries may also be provided such as line graphs and pie charts (seeFIGS. 12-13). The user may be able to select a point on a line graph and see the logbook entry associated with that point.
• Thediabetes management application154 may be configured with diabetes management tools such as carbohydrate tables, insulin tables, fast acting carbohydrate list, daily regimen (food and exercise patterns) and target glucose levels. Theapplication154 may process one or more carbohydrate tables and a food database. The user may be able to choose entries from a database listing carbohydrate values of foods per listed serving size. The user may be able to customize the food database by adding food items to the food database. The user may be able to tag entries as “quick picks”. Thediabetes management application154 may include a lookup table containing the dose of insulin required to lower glucose concentration by a known amount. The user may input insulin dosages based on a health care professional's recommendations.
• One or more of the applications150-156 may be configured to issue “alerts”. These alerts may be warnings directed to the user that are audible, or otherwise sensory such as by vibration, and displayed with graphics and/or text using the display screen on the PDA. Alerts may indicate that a planned activity is due to begin. Event markers may be used to indicate that the user makes an entry into thelogbook158 to designate a specific condition or incident that relates to a specific blood glucose measurement such as meals, time before or after exercise, medication taken, sickness, feeling hypoglycemic, etc. The applications150-156, and particularly thediabetes management application154, may be used for self-monitoring of glucose in whole blood, and may be used by people with diabetes and by healthcare professionals as an aid to monitor the effectiveness of diabetes management.
• The applications150-156, and particularly themeter application150, may be used to provide direction to a user taking a glucose measurement and control data flow to thelogbook158. For example, when the user inserts a test strip into the module, the module is programmed to check the strip and perform a self test. The display then indicates to the user when to apply the blood. The user then applies the blood sample to the strip. The measurement module monitors for fill (the PDA may, e.g., beep on fill) and takes the measurement. The module is programmed to then determine the glucose level and the PDA displays the result. The glucose value is then automatically entered into the electronic logbook, i.e., without user intervention, and the meter waits for further user input. Once the glucose measurement is complete, themeter application150 may be configured to relinquish control to one or more of the other applications152-156.
• FIG. 12 illustrates a line graph of blood glucose data generated by an integrated measurement module and PDA according to a preferred embodiment. The data used to generate this graph is stored in the logbook database. The line graph ofFIG. 12 shows glucose levels according to the date that the glucose level was taken. As shown, a glucose level that was recorded on November 5 at around 500 mg/dL is labeled as being “Hi” while a glucose level recorded on October 21 at around 20 mg/dL is labeled as “Lo”. A range between around 80 mg/dL and 140 mg/dL is indicated by dashed lines inFIG. 12 suggesting an optimal glucose level range.
• FIG. 13 illustrates pie charts of blood glucose data generated by an integrated measurement module and PDA according to a preferred embodiment. The data used to generate the illustrative graphs ofFIG. 13 is stored in the logbook database. All of the pie charts shown inFIG. 13 may be displayed on adisplay screen166 of the PDA at the same time, or one or more may be displayed at a single time. The graphs show the percentage of readings that are below, within or above target. For example, chart (a) shows that overall 39% of the time the readings are within target or within the optimal glucose level range ofFIG. 12. Charts (b)-(g) show the percentages of readings that are below, within or above target pre-breakfast, pre-lunch, pre-dinner, post-breakfast, post-lunch and post-dinner, respectively. The user can understand his or her glucose level trends from these graphs.
• As described above, the advantageousglucose measurement module2, as schematically shown, e.g., atFIG. 1, including its rounded-contour, tapered-shape narrowed end portion protruding from an inset shoulder of a connector end, and its composition, facilitates off-finger or alternate site testing. Thestrip8, and/or any of various embodiments thereof are described at PCT published application No. WO 01/33216 and U.S. patent application Ser. No. 09/434,026, which are assigned to the same assignee as the present application and are hereby incorporated by reference. For example, the invention may use an electrochemical coulometric test strip such as the FreeStyle brand strip sold by TheraSense, Inc. of Alameda, Calif. The FreeStyle strip uses a so-called “side-fill” arrangement.
• “Coulometry” is the determination of charge passed or projected to pass during complete or nearly complete electrolysis of the analyte, either directly on the electrode or through one or more electron transfer agents. The charge is determined by measurement of charge passed during partial or nearly complete electrolysis of the analyte or, more often, by multiple measurements during the electrolysis of a decaying current and elapsed time. The decaying current results from the decline in the concentration of the electrolyzed species caused by the electrolysis. “Amperometry”, another method of electrochemically measuring glucose, includes steady-state amperometry, chronoamperometry, and Cottrell-type measurements.
• While exemplary drawings and specific embodiments of the present invention have been described and illustrated, it is to be understood that that the scope of the present invention is not to be limited to the particular embodiments discussed. Thus, the embodiments shall be regarded as illustrative rather than restrictive, and it should be understood that variations may be made in those embodiments by workers skilled in the arts without departing from the scope of the present invention as set forth in the claims that follow, and equivalents thereof.
• In addition, in the method claims that follow, the steps have been ordered in selected typographical sequences. However, the sequences have been selected and so ordered for typographical convenience and are not intended to imply any particular order for performing the steps, except for those claims wherein a particular ordering of steps is expressly set forth or understood by one of ordinary skill in the art as being necessary.

Claims (48)

1.-28. (canceled)

29. A hand-held processing device, comprising:

a housing configured to be hand-held;

a memory comprising one or more software programs;

a processor coupled to the housing, wherein the processor is configured to process data associated with monitoring a health condition using the one or more software programs;

a display unit coupled to the housing and in communication with the processor for displaying the data associated with the monitoring of the health condition; and

a communication unit coupled to the housing and in communication with the processor, wherein the communication unit is configured to receive data and/or software programs from a computer and/or network to the hand-held processing device.

30. The hand-held processing device ofclaim 29, wherein the health condition is diabetes.

31. The hand-held processing device ofclaim 30, wherein the data associated with the monitoring of the health condition comprises data indicative of an analyte concentration in a sample from a subject having the health condition.

32. The hand-held processing device ofclaim 31, wherein the analyte is glucose.

33. The hand-held processing device ofclaim 29, wherein the processing device comprises a measurement module for testing at least one physical parameter of a subject having the health condition.

34. The hand-held processing device ofclaim 33, wherein the measurement module comprises a test strip receptacle coupled to the housing and in communication with the housing.

35. The hand-held processing device ofclaim 34, wherein the test strip receptacle is configured to receive a glucose test strip.

36. The hand-held processing device ofclaim 29, wherein the display unit comprises a liquid crystal display (LCD).

37. The hand-held processing device ofclaim 29, wherein the display unit comprises a touchscreen.

38. The hand-held processing device ofclaim 29, wherein the hand-held processing device is configured to issue one or more communications to a user of the hand-held processing device.

39. The hand-held processing device ofclaim 38, wherein the one or more communications are selected from an audible communication, a vibratory communication, a graphical communication and a textual communication.

40. The hand-held processing device ofclaim 38, wherein the one or more communications indicate that a planned activity is due to begin.

41. The hand-held processing device ofclaim 40, wherein the planned activity is user entry of data associated with the monitoring of the health condition.

42. The hand-held processing device ofclaim 41, wherein the data associated with the monitoring of the health condition comprises exercise data.

43. The hand-held processing device ofclaim 41, wherein the data associated with the monitoring of the health condition comprises dietary data.

44. The hand-held processing device ofclaim 43, wherein the dietary data comprises meal-related data.

45. The hand-held processing device ofclaim 44, wherein the meal-related data comprises meal time data.

46. The hand-held processing device ofclaim 44, wherein the meal-related data comprises carbohydrate value.

47. The hand-held processing device ofclaim 31, wherein the analyte is glucose, and wherein the display unit is configured to display a communication activatable when the glucose concentration of the sample indicates hyperglycemia, hypoglycemia, impending hyperglycemia, or impending hypoglycemia.

48. The hand-held processing device ofclaim 29, wherein the hand-held processing device comprises a PDA, a mobile phone, or a combination PDA/mobile phone.

49. The hand-held processing device ofclaim 29, wherein the hand-held processing device is configured for USB connectivity with a personal computer.

50. The hand-held processing device ofclaim 29, wherein the network is a computer network.

51. The hand-held processing device ofclaim 29, wherein the communication with the computer and/or network is wireless communication.

52. The hand-held processing device ofclaim 51, wherein the wireless communication is by RF and/or IR.

53. The hand-held processing device ofclaim 29, wherein the communication unit is configured for connection with the internet.

54. The hand-held processing device ofclaim 29, wherein the communication unit is configured for communication with a personal computer, and wherein the processor is configured to synchronize data in the hand-held processing device with data in the personal computer to produce synchronized data.

55. The hand-held processing device ofclaim 54, wherein the synchronized data comprises time- and/or date-tagged event data.

56. The hand-held processing device ofclaim 29, further comprising diabetes management software configured to be accessed by a health care professional.

57. The hand-held processing device ofclaim 29, further comprising a database comprising data associated with the monitoring of the health condition, wherein the database is accessible by a user of the hand-held processing device.

58. The hand-held processing device ofclaim 57, wherein the data associated with the monitoring of the health condition is event data.

59. The hand-held processing device ofclaim 57, wherein at least a portion of the data associated with the monitoring of the health condition is manually entered by the user of the hand-held processing device.

60. The hand-held processing device ofclaim 57, further comprising application software configured to merge the data associated with the monitoring of the health condition with additional data specific for the user of the hand-held processing device.

61. The hand-held processing device ofclaim 29, further comprising application software configured to store and retrieve data associated with the monitoring of the health condition such that the data associated with the monitoring of the health condition is accessible by a user of the hand-held processing device.

62. The hand-held processing device ofclaim 61, wherein the application software is configured to receive and store user-entered data associated with the monitoring of the health condition.

63. The hand-held processing device ofclaim 62, wherein the application software is configured to display one or more pre-defined drop-down lists from which a user can select data associated with the monitoring of the health condition.

64. The hand-held processing device ofclaim 61, wherein the data associated with the monitoring of the health condition comprises carbohydrate data.

65. The hand-held processing device ofclaim 61, wherein the data associated with the monitoring of the health condition comprises exercise data.

66. The hand-held processing device ofclaim 64, wherein the hand-held processing device comprises a food database accessible by a user of the analyte measurement system, wherein the food database comprises carbohydrate values for food items.

67. The hand-held processing device ofclaim 66, wherein the food database is customizable by the user of the hand-held processing device.

68. The hand-held processing device ofclaim 29, wherein the display unit is configured to display a recommended treatment to a user of the hand-held processing device.

69. The hand-held processing device ofclaim 31, wherein the hand-held processing device further comprises application software configured to determine a dosage of medication based at least in part on the indicated analyte concentration.

70. The hand-held processing device ofclaim 69, wherein the analyte is glucose and the medication is insulin.

71. The hand-held processing device ofclaim 31, wherein the hand-held processing device further comprises application software configured to determine trending of analyte concentration based at least in part on the indicated analyte concentration.

72. The hand-held processing device ofclaim 71, wherein the trending provides for a rate and/or acceleration of analyte concentration increase or decrease.

73. The hand-held processing device ofclaim 71, wherein the application software is configured to communicate with the display unit such that visual indicators of analyte concentration trending are displayed to a user of the hand-held processing device.

74. The hand-held processing device ofclaim 29, wherein the hand-held processing device further comprises application software configured to communicate with the display unit such that a visual representation of data associated with the monitoring of the health condition over time is provided to a user of the hand-held processing device.

75. The hand-held processing device ofclaim 32, wherein the hand-held processing device further comprises application software configured to communicate with the display unit such that a visual representation of glucose concentration over time is provided to a user of the hand-held processing device.

Images